Gene · 2202
Papers1,739
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
461 to 480 of 1,739
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Association of 71 cardiovascular disease-related plasma proteins with pulmonary function in the community. | PLoS One | 2022 | 35390066 | PubTator, text mining | PubMed |
| Single-cell transcriptome analysis reveals aberrant stromal cells and heterogeneous endothelial cells in alcohol-induced osteonecrosis of the femoral head. | Commun Biol | 2022 | 35388143 | PubTator, text mining | PubMed |
| Extracellular vesicles and chronic obstructive pulmonary disease (COPD): a systematic review. | Respir Res | 2022 | 35382831 | PubTator, text mining | PubMed |
| LGR5 expressing skin fibroblasts define a major cellular hub perturbed in scleroderma. | Cell | 2022 | 35381199 | PubTator, text mining | PubMed |
| Ingredients of a Natural Oral Nutritional Supplement and Their Role in the Treatment of Osteoarthritis. | Clin Med Insights Arthritis Musculoskelet Disord | 2022 | 35360183 | PubTator, text mining | PubMed |
| Rare and common variants in ROM1 and PRPH2 genes trans-modify Stargardt/ABCA4 disease. | PLoS Genet | 2022 | 35353811 | PubTator, text mining | PubMed |
| Assessing Variant Causality and Severity Using Retinal Pigment Epithelial Cells Derived from Stargardt Disease Patients. | Transl Vis Sci Technol | 2022 | 35348597 | PubTator, text mining | PubMed |
| Notch signaling pathway: architecture, disease, and therapeutics. | Signal Transduct Target Ther | 2022 | 35332121 | PubTator, text mining | PubMed |
| In silico Analysis of Publicly Available Transcriptomics Data Identifies Putative Prognostic and Therapeutic Molecular Targets for Papillary Thyroid Carcinoma. | Int J Gen Med | 2022 | 35330879 | PubTator, text mining | PubMed |
| Interrogation of RDEB Epidermal Allografts after BMT Reveals Coexpression of Collagen VII and Keratin 15 with Proinflammatory Immune Cells and Fibroblasts. | J Invest Dermatol | 2022 | 35304249 | PubTator, text mining | PubMed |
| Harnessing secretory pathway differences between HEK293 and CHO to rescue production of difficult to express proteins. | Metab Eng | 2022 | 35301123 | PubTator, text mining | PubMed |
| Identification of CD14 and lipopolysaccharide-binding protein as novel biomarkers for sarcoidosis using proteomics of serum extracellular vesicles. | Int Immunol | 2022 | 35294531 | PubTator, text mining | PubMed |
| HSF2 cooperates with HSF1 to drive a transcriptional program critical for the malignant state. | Sci Adv | 2022 | 35294249 | PubTator, text mining | PubMed |
| TAILS Identifies Candidate Substrates and Biomarkers of ADAMTS7, a Therapeutic Protease Target in Coronary Artery Disease. | Mol Cell Proteomics | 2022 | 35283288 | PubTator, text mining | PubMed |
| Differential mitochondrial and cellular responses between H vs. J mtDNA haplogroup-containing human RPE transmitochondrial cybrid cells. | Exp Eye Res | 2022 | 35283109 | PubTator, text mining | PubMed |
| Research Progress of Olfactory Nerve Regeneration Mechanism and Olfactory Training. | Ther Clin Risk Manag | 2022 | 35281777 | PubTator, text mining | PubMed |
| Radiation increases COL1A1, COL3A1, and COL1A2 expression in breast cancer. | Open Med (Wars) | 2022 | 35274048 | PubTator, text mining | PubMed |
| Differences in potential key genes and pathways between primary and radiation-associated angiosarcoma of the breast. | Transl Oncol | 2022 | 35263699 | PubTator, text mining | PubMed |
| Glioblastoma Microenvironment and Cellular Interactions. | Cancers (Basel) | 2022 | 35205842 | PubTator, text mining | PubMed |
| Diagnostic Modalities of Non-Alcoholic Fatty Liver Disease: From Biochemical Biomarkers to Multi-Omics Non-Invasive Approaches. | Diagnostics (Basel) | 2022 | 35204498 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/2202/papers?page=24